EXPERIMENTAL STUDY
Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia
Inna Frolkis, MD, PhDa,
Jacob Gurevitch, MDa,
Yael Yuhas, PhDb,
Adrian Iaina, MDc,
Yoram Wollman, PhDc,
Tamara Chernichovski, MScc,
Yosef Paz, MDa,
Menachem Matsa, MDa,
Dimitri Pevni, MDa,
Amir Kramer, MDa,
Itzhak Shapira, MDa and
Rephael Mohr, MDa
a Department of Thoracic and Cardiovascular Surgery, Tel Aviv Medical Center, Tel Aviv, Israel
b Felsenstein Medical Research Center, Petah Tikva, Israel
c Department of Nephrology, Tel Aviv Medical Center, Tel Aviv, Israel
Manuscript received August 13, 1999;
revised manuscript received July 24, 2000,
accepted September 13, 2000.
Reprint requests and correspondence: Dr. Inna Frolkis, Department of Thoracic and Cardiovascular Surgery Tel Aviv Medical Center, 6 Weizman Street, Tel-Aviv 64239, Israel
OBJECTIVES
The purpose of this study was to explore interactions between paracrine angiotensin II (Ang-II) and tumor necrosis factor-alpha (TNF-alpha) during myocardial ischemia.
BACKGROUND
Ischemic myocardium releases significant amounts of TNF-alpha. This paracrine release correlated with postischemic myocardial injury. Other studies showed myocardial protection obtained by the use of angiotensin-converting enzyme inhibitors (i.e., captopril) and the Ang-II type 1 receptor antagonist losartan after ischemia. The possibility that these agents decrease TNF-alpha synthesis has not yet been investigated.
METHODS
Using the modified Langendorff model, isolated rat hearts underwent either 90 min of nonischemic perfusion (control group) or 1 h of global cardioplegic ischemia. In both groups, either captopril (360 µmol/liter) or losartan (182.2 µmol/liter) was added before ischemia. The hearts were assayed for messenger ribonucleic acid (mRNA) expression and effluent TNF-alpha levels. In addition, cardiac myocytes were incubated in cell culture with Ang-II.
RESULTS
After ischemia, TNF-alpha mRNA expression intensified from 0.63 ± 0.06 (control group) to 0.92 ± 0.12 (p < 0.03), and effluent TNF-alpha levels were 711 ± 154 pg/ml. The TNF-alpha mRNA expression declined to 0.46 ± 0.07 (p < 0.01) and 0.65 ± 0.08 (p < 0.02) in captopril- and losartan-treated hearts, respectively. Effluent TNF-alpha was below detectable levels. Concentrations of TNF-alpha in supernatants of incubated cardiac myocytes treated with 10 and 50 nmol/liter of Ang-II were 206.0 ± 47.0 pg/ml and 810 ± 130 pg/ml, respectively (p < 0.004). When pretreated with 700 µmol/liter of losartan, TNF-alpha was below detectable levels.
CONCLUSIONS
This study presents an original explanation for previously reported myocardial protection after ischemia, obtained by the use of captopril and losartan. These drugs reduce TNF-alpha synthesis, providing strong evidence of active interactions between paracrine TNF-alpha and Ang-II in the evolution of the ischemic cascade.
|
Abbreviations and Acronyms
| | ACE | = angiotensin-converting enzyme | | Ang-II | = angiotensin II | | cDNA | = complementary deoxyribonucleic acid | | GAPD | = glyceraldehyde-3-phosphate dehydrogenase | | LV | = left ventricular | | mAb | = monoclonal antibody | | mRNA | = messenger ribonucleic acid | | PCR | = polymerase chain reaction | | RAS | = renin-angiotensin system | | TNF-alpha | = tumor necrosis factor-alpha |
|
This article has been cited by other articles:

|
 |

|
 |
 
A. Guggilam, K. P. Patel, M. Haque, P. J. Ebenezer, D. R. Kapusta, and J. Francis
Cytokine blockade attenuates sympathoexcitation in heart failure: Cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus
Eur J Heart Fail,
July 1, 2008;
10(7):
625 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Li, J. Zimpelmann, K. Cheng, J. A. Wilkins, and K. D. Burns
The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules
Am J Physiol Renal Physiol,
February 1, 2005;
288(2):
F353 - F362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sekiguchi, X. Li, M. Coker, M. Flesch, P. M Barger, N. Sivasubramanian, and D. L Mann
Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure
Cardiovasc Res,
August 15, 2004;
63(3):
433 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|